Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | APG-1252 |
Trade Name | |
Synonyms | BM-1252|Pelcitoclax|APG1252|APG 1252 |
Drug Descriptions |
Pelcitoclax (APG-1252) inhibits BCL2 and BCL-XL, potentially resulting in increased tumor cell apoptosis and decreased tumor growth (Eur J Cancer, 2014, Vol 50 , pp.109-10). |
DrugClasses | BCL-XL inhibitor 13 BCL2 inhibitor 23 |
CAS Registry Number | 1619923-36-2 |
NCIT ID | C148488 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
APG-1252 | APG-1252 | 0 | 1 |
APG-1252 + Paclitaxel | APG-1252 Paclitaxel | 0 | 1 |